1. Home
  2. SRI vs QNCX Comparison

SRI vs QNCX Comparison

Compare SRI & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$5.49

Market Cap

161.7M

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$0.09

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
QNCX
Founded
1965
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.7M
167.0M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
SRI
QNCX
Price
$5.49
$0.09
Analyst Decision
Buy
Hold
Analyst Count
1
3
Target Price
$16.00
$10.00
AVG Volume (30 Days)
205.9K
16.7M
Earning Date
03-11-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$824,444,000.00
N/A
Revenue This Year
$7.42
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.46
N/A
52 Week Low
$3.54
$0.08
52 Week High
$9.71
$4.55

Technical Indicators

Market Signals
Indicator
SRI
QNCX
Relative Strength Index (RSI) 25.54 27.32
Support Level N/A N/A
Resistance Level $8.79 $0.98
Average True Range (ATR) 0.36 0.01
MACD -0.25 0.07
Stochastic Oscillator 5.88 12.39

Price Performance

Historical Comparison
SRI
QNCX

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: